Glück Conviction Score™ ⓘ
VCYT
VERACYTE, INC.
🟢
Conviction × Timing — fundamental hohe Conviction trifft auf ein positiv drehendes Timing (Momentum/FTD). Der günstige Quadrant des Modells.
Effektiv: Stark
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
48,8
46 neu, 143 erhöht, -960521K $ netto
Aktivist
38,1
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 39.21 | +20.7 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 38.00 | +24.5 % vs SMA200 | |
| SMA-Cross | Bullisch | 10 % | GOLDEN | vor 5 Tagen @ 48.73 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 45.76 | EMA50: 41.56 | |
| MACD-Histogramm | Bärisch | 10 % | -0.343 | Bearisch | |
| RSI(14) | Neutral | 10 % | 59.8 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 57.1 | Neutral | |
| ADX(14)+DI | Bullisch | 10 % | 28.2 | +DI: 23.6 / −DI: 19.1 | |
| Z-Score(60) | Neutral | 5 % | 1.45 | In Range | |
| 52W-Position | Bullisch | 5 % | 90.3 % | Hoch 49.94 / Tief 23.03 | |
| Bollinger(20,2σ) | Neutral | 5 % | 60.3 % | Upper 51.90 / Mid 46.14 / Lower 40.39 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.3373 | R²=0.83 / annualisiert +223.4 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -1.600 | 49,28 | -78.853,76 | -19,5% | |
| 2026-06-04 | McGuire Annie | Officer, EVP, General Counsel | Open Market Sale | -1.776 | 50,12 | -89.007,44 | -22,0% | |
| 2026-06-04 | McGuire Annie | Officer, EVP, General Counsel | Open Market Sale | -1.400 | 49,31 | -69.028,54 | -17,1% | |
| 2026-06-04 | Leite John | Officer, Global Chief Commercial Off | Open Market Sale | -13.975 | 50,07 | -699.732,44 | -172,9% | |
| 2026-06-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -138.051 | 50,12 | -6.919.585,49 | -1709,3% | |
| 2026-06-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -1.961 | 50,09 | -98.229,04 | -24,3% | |
| 2026-05-22 | Wygant Jonathan | Officer, VP, Chief Accounting Officer | Open Market Sale | -24.000 | 45,40 | -1.089.624,00 | -269,2% | |
| 2026-05-20 | EPSTEIN ROBERT S | Director | Open Market Sale | -10.000 | 44,01 | -440.129,00 | -108,7% | |
| 2026-05-06 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -5.102 | 38,05 | -194.131,10 | -48,0% | |
| 2026-05-06 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -5.102 | 40,00 | -204.080,00 | -50,4% | |
| 2026-03-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -4.994 | 35,29 | -176.256,24 | -43,5% | |
| 2026-03-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -26.279 | 36,28 | -953.367,96 | -235,5% | |
| 2026-03-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -19.244 | 35,56 | -684.226,19 | -169,0% | |
| 2026-03-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -13.941 | 36,33 | -506.459,80 | -125,1% | |
| 2026-03-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -4.400 | 35,55 | -156.409,44 | -38,6% | |
| 2026-03-04 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -5.260 | 35,19 | -185.082,57 | -45,7% | |
| 2026-03-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -1.664 | 36,34 | -60.468,60 | -14,9% | |
| 2026-03-02 | Febbo Phillip G. | Officer, Chief Scientific & Med Officer | Open Market Sale | -13.425 | 36,16 | -485.429,21 | -119,9% | |
| 2025-12-16 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -100 | 43,68 | -4.368,00 | -1,1% | |
| 2025-12-16 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -10.639 | 43,13 | -458.835,60 | -113,3% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -12.808 | 45,84 | -587.080,30 | -145,0% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -6.392 | 44,52 | -284.571,20 | -70,3% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -800 | 46,59 | -37.271,84 | -9,2% | |
| 2025-12-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -720 | 47,10 | -33.908,76 | -8,4% | |
| 2025-12-04 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -1.278 | 47,51 | -60.717,78 | -15,0% | |
| 2025-12-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -3.220 | 47,35 | -152.462,17 | -37,7% | |
| 2025-12-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -4.448 | 46,90 | -208.613,42 | -51,5% | |
| 2025-12-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -702 | 47,51 | -33.352,02 | -8,2% | |
| 2025-12-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -4.741 | 47,25 | -224.008,93 | -55,3% | |
| 2025-12-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -8.537 | 46,61 | -397.946,28 | -98,3% | |
| 2025-11-25 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -2.808 | 50,00 | -140.400,00 | -34,7% | |
| 2025-11-25 | JONES EVAN/ FA | Director | Open Market Sale | -1.106 | 50,25 | -55.575,73 | -13,7% | |
| 2025-11-20 | Holstein Jens | Director | Open Market Sale | -1.491 | 40,95 | -61.060,33 | -15,1% | |
| 2025-11-20 | Holstein Jens | Director | Open Market Sale | -1.460 | 43,21 | -63.085,87 | -15,6% | |
| 2025-11-20 | Holstein Jens | Director | Open Market Sale | -7.049 | 42,48 | -299.416,85 | -74,0% | |
| 2025-11-10 | Wygant Jonathan | Officer, VP, Chief Accounting Officer | Open Market Sale | -5.102 | 42,33 | -215.978,37 | -53,4% | |
| 2025-11-07 | Wygant Jonathan | Officer, VP, Chief Accounting Officer | Open Market Sale | -5.818 | 40,21 | -233.928,98 | -57,8% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -657 | 46,38 | -30.468,77 | -7,5% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -408 | 41,74 | -17.031,18 | -4,2% | |
| 2025-11-05 | EASTHAM KARIN | Director | Open Market Sale | -9.674 | 40,02 | -387.191,21 | -95,6% | |
| 2025-11-05 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -7.000 | 41,00 | -287.000,00 | -70,9% | |
| 2025-11-05 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -6.466 | 40,00 | -258.640,00 | -63,9% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -24.296 | 45,73 | -1.110.990,48 | -274,4% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -10.837 | 43,80 | -474.701,78 | -117,3% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -5.872 | 45,07 | -264.640,47 | -65,4% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -1.126 | 43,03 | -48.455,05 | -12,0% | |
| 2025-10-06 | Febbo Phillip G. | Officer, Chief Scientific & Med Officer | Open Market Sale | -8.349 | 36,02 | -300.709,27 | -74,3% | |
| 2025-10-01 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -2.160 | 35,00 | -75.607,56 | -18,7% | |
| 2025-10-01 | EPSTEIN ROBERT S | Director | Open Market Sale | -21.473 | 35,08 | -753.204,13 | -186,1% | |
| 2025-10-01 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -2.539 | 35,00 | -88.865,00 | -22,0% | |
| 2025-09-19 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -2.283 | 33,69 | -76.919,52 | -19,0% | |
| 2025-09-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -7.667 | 30,41 | -233.132,77 | -57,6% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13.172.618 | 13.128.801 | 43.817 | 424.290.027 | Aufgestockt | +0,3% | |
| VANGUARD GROUP INC | 8.504.011 | 0 | 8.504.011 | 358.018.863 | Neu | +100,0% | |
| FMR LLC | 7.763.849 | 5.738.209 | 2.025.640 | 250.073.568 | Aufgestockt | +35,3% | |
| Artisan Partners Limited Partnership | 5.496.370 | 6.263.041 | -766.671 | 177.038.065 | Reduziert | -12,2% | |
| STATE STREET CORP | 5.043.590 | 4.360.913 | 682.677 | 162.454.034 | Aufgestockt | +15,7% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.532.232 | 0 | 3.532.232 | 113.773.193 | Neu | +100,0% | |
| ARK Investment Management LLC | 3.053.818 | 3.887.547 | -833.729 | 98.363.488 | Reduziert | -21,4% | |
| DIMENSIONAL FUND ADVISORS LP | 2.881.090 | 2.800.476 | 80.614 | 92.787.245 | Aufgestockt | +2,9% | |
| WELLINGTON MANAGEMENT GROUP LLP | 2.558.285 | 2.036.386 | 521.899 | 82.402.360 | Aufgestockt | +25,6% | |
| FIRST TRUST ADVISORS LP | 2.117.046 | 1.283.503 | 833.543 | 68.190.051 | Aufgestockt | +64,9% | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.957.096 | 1.900.882 | 56.214 | 63.049.182 | Aufgestockt | +3,0% | |
| BANK OF AMERICA CORP /DE/ | 1.448.897 | 1.262.968 | 185.929 | 46.668.973 | Aufgestockt | +14,7% | |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.414.362 | 1.381.437 | 32.925 | 45.556.610 | Aufgestockt | +2,4% | |
| ArrowMark Colorado Holdings LLC | 1.374.103 | 1.561.449 | -187.346 | 44.259.858 | Reduziert | -12,0% | |
| Iron Triangle Partners LP | 980.391 | 0 | 980.391 | 41.274.461 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1.276.260 | 1.194.327 | 81.933 | 41.108.335 | Aufgestockt | +6,9% | |
| Sumitomo Mitsui Trust Group, Inc. | 1.055.656 | 1.257.898 | -202.242 | 34.002.680 | Reduziert | -16,1% | |
| Amova Asset Management Americas, Inc. | 1.045.047 | 1.257.898 | -212.851 | 33.629.612 | Reduziert | -16,9% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 989.687 | 790.425 | 199.262 | 31.877.818 | Aufgestockt | +25,2% | |
| NORTHERN TRUST CORP | 929.500 | 992.196 | -62.696 | 29.939.195 | Reduziert | -6,3% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 923.573 | 910.829 | 12.744 | 29.748.286 | Aufgestockt | +1,4% | |
| Legal & General Group Plc | 897.171 | 690.757 | 206.414 | 28.897.877 | Aufgestockt | +29,9% | |
| OBERWEIS ASSET MANAGEMENT INC/ | 839.834 | 726.740 | 113.094 | 27.051.053 | Aufgestockt | +15,6% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 631.710 | 0 | 631.710 | 26.594.991 | Neu | +100,0% | |
| Alyeska Investment Group, L.P. | 808.570 | 601.556 | 207.014 | 26.044.040 | Aufgestockt | +34,4% | |
| MORGAN STANLEY | 797.802 | 1.183.069 | -385.267 | 25.697.233 | Reduziert | -32,6% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 570.720 | 0 | 570.720 | 24.027.477 | Neu | +100,0% | |
| Fisher Asset Management, LLC | 736.270 | 795.712 | -59.442 | 23.715.255 | Reduziert | -7,5% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 726.000 | 726.000 | 0 | 23.384.460 | Unverändert | 0,0% | |
| JPMORGAN CHASE & CO | 520.129 | 0 | 520.129 | 21.897.432 | Neu | +100,0% | |
| BAMCO INC /NY/ | 655.522 | 645.621 | 9.901 | 21.114.364 | Aufgestockt | +1,5% | |
| SEGALL BRYANT & HAMILL, LLC | 591.488 | 596.305 | -4.817 | 19.051.828 | Reduziert | -0,8% | |
| FRED ALGER MANAGEMENT, LLC | 579.460 | 633.894 | -54.434 | 18.664.407 | Reduziert | -8,6% | |
| ROYAL BANK OF CANADA | 573.096 | 344.376 | 228.720 | 18.459.000 | Aufgestockt | +66,4% | |
| Point72 Asset Management, L.P. | 483.904 | 426.229 | 57.675 | 15.586.548 | Aufgestockt | +13,5% | |
| PRINCIPAL FINANCIAL GROUP INC | 476.686 | 465.384 | 11.302 | 15.354.056 | Aufgestockt | +2,4% | |
| Invesco Ltd. | 436.587 | 390.770 | 45.817 | 14.062.468 | Aufgestockt | +11,7% | |
| NEW YORK STATE COMMON RETIREMENT FUND | 421.633 | 586.242 | -164.609 | 13.580.799 | Reduziert | -28,1% | |
| SEI INVESTMENTS CO | 420.093 | 385.784 | 34.309 | 13.531.202 | Aufgestockt | +8,9% | |
| BNP PARIBAS FINANCIAL MARKETS | 362.836 | 352.621 | 10.215 | 11.686.948 | Aufgestockt | +2,9% | |
| JUPITER ASSET MANAGEMENT LTD | 355.604 | 355.604 | 0 | 11.454.005 | Unverändert | 0,0% | |
| RAYMOND JAMES FINANCIAL INC | 370.261 | 384.329 | -14.068 | 11.355.744 | Reduziert | -3,7% | |
| AEGON ASSET MANAGEMENT UK PLC | 326.627 | 489.418 | -162.791 | 10.510.857 | Reduziert | -33,3% | |
| Soleus Capital Management, L.P. | 319.912 | 10.000 | 309.912 | 10.304.366 | Aufgestockt | +3099,1% | |
| BALYASNY ASSET MANAGEMENT L.P. | 298.955 | 0 | 298.955 | 9.629.341 | Neu | +100,0% | |
| Granite Investment Partners, LLC | 298.589 | 351.038 | -52.449 | 9.617.552 | Reduziert | -14,9% | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 282.835 | 273.633 | 9.202 | 9.110.115 | Aufgestockt | +3,4% | |
| Champlain Investment Partners, LLC | 281.923 | 688.782 | -406.859 | 9.080.740 | Reduziert | -59,1% | |
| Casdin Capital, LLC | 276.308 | 276.308 | 0 | 8.899.881 | Unverändert | 0,0% | |
| Nuveen, LLC | 238.439 | 582.274 | -343.835 | 7.680.120 | Reduziert | -59,1% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13.172.618 | 13.128.801 | +0,3% | 424.290.027 | 16,31 |
| FMR LLC | 7.763.849 | 5.738.209 | +35,3% | 250.073.568 | 9,61 |
| Artisan Partners Limited Partnership | 5.496.370 | 6.263.041 | -12,2% | 177.038.065 | 6,81 |
| STATE STREET CORP | 5.043.590 | 4.360.913 | +15,7% | 162.454.034 | 6,25 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.532.232 | 0 | +100,0% | 113.773.193 | 4,37 |
| ARK Investment Management LLC | 3.053.818 | 3.887.547 | -21,4% | 98.363.488 | 3,78 |
| DIMENSIONAL FUND ADVISORS LP | 2.881.090 | 2.800.476 | +2,9% | 92.787.245 | 3,57 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.558.285 | 2.036.386 | +25,6% | 82.402.360 | 3,17 |
| FIRST TRUST ADVISORS LP | 2.117.046 | 1.283.503 | +64,9% | 68.190.051 | 2,62 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.957.096 | 1.900.882 | +3,0% | 63.049.182 | 2,42 |
| BANK OF AMERICA CORP /DE/ | 1.448.897 | 1.262.968 | +14,7% | 46.668.973 | 1,79 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.414.362 | 1.381.437 | +2,4% | 45.556.610 | 1,75 |
| ArrowMark Colorado Holdings LLC | 1.374.103 | 1.561.449 | -12,0% | 44.259.858 | 1,70 |
| GOLDMAN SACHS GROUP INC | 1.276.260 | 1.194.327 | +6,9% | 41.108.335 | 1,58 |
| Sumitomo Mitsui Trust Group, Inc. | 1.055.656 | 1.257.898 | -16,1% | 34.002.680 | 1,31 |
| Amova Asset Management Americas, Inc. | 1.045.047 | 1.257.898 | -16,9% | 33.629.612 | 1,29 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 989.687 | 790.425 | +25,2% | 31.877.818 | 1,23 |
| NORTHERN TRUST CORP | 929.500 | 992.196 | -6,3% | 29.939.195 | 1,15 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 923.573 | 910.829 | +1,4% | 29.748.286 | 1,14 |
| Legal & General Group Plc | 897.171 | 690.757 | +29,9% | 28.897.877 | 1,11 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 331 | 92,2 | 2.900 |
| 31.12.2025 | ✓ | 324 | 90,4 | 3.730 |
| 30.09.2025 | ✓ | 298 | 92,6 | 3.113 |
| 30.06.2025 | ✓ | 272 | 87,9 | 2.271 |
| 31.03.2025 | ✓ | 284 | 90,2 | 2.554 |
| 31.12.2024 | ✓ | 313 | 84,7 | 3.178 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.381.437 | 58.158.490 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 631.710 | 26.594.991 |
| Point72 Asset Management, L.P. | 426.229 | 17.944.241 |
| EFG International AG | 133.049 | 5.602.684 |
| Corient Private Wealth LLC | 130.037 | 5.474.919 |
| Caption Management, LLC | 129.500 | 5.451.950 |
| ARDSLEY ADVISORY PARTNERS LP | 125.000 | 5.262.500 |
| BROWN CAPITAL MANAGEMENT LLC | 114.157 | 4.806.010 |
| MOORE CAPITAL MANAGEMENT, LP | 42.765 | 1.800.407 |
| Westview Management dba Westview Investment Advisors | 32.690 | 1.376.249 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Iron Triangle Partners LP | 980.391 | 495.391 | +102.1 % | 41.274.461 |
| Alyeska Investment Group, L.P. | 601.556 | 293.503 | +95.3 % | 25.325.508 |
| MORGAN STANLEY | 1.183.069 | 283.091 | +31.5 % | 49.807.317 |
| BNP PARIBAS FINANCIAL MARKETS | 352.621 | 281.079 | +392.9 % | 14.845.344 |
| ROYAL BANK OF CANADA | 344.376 | 277.302 | +413.4 % | 14.499.000 |
| JANUS HENDERSON GROUP PLC | 271.623 | 237.297 | +691.3 % | 11.435.672 |
| RAYMOND JAMES FINANCIAL INC | 384.329 | 187.334 | +95.1 % | 16.241.144 |
| BLAIR WILLIAM & CO/IL | 191.703 | 176.294 | +1144.1 % | 8.070.696 |
| STATE STREET CORP | 4.360.913 | 161.239 | +3.8 % | 183.594.437 |
| Walleye Capital LLC | 165.583 | 133.874 | +422.2 % | 6.971.044 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 2.036.386 | -1.336.838 | -39.6 % | 85.731.851 |
| Artisan Partners Limited Partnership | 6.263.041 | -1.107.426 | -15.0 % | 263.674.034 |
| FMR LLC | 5.738.209 | -1.057.488 | -15.6 % | 241.578.608 |
| ArrowMark Colorado Holdings LLC | 1.561.449 | -984.290 | -38.7 % | 65.737.003 |
| ARK Investment Management LLC | 3.887.547 | -578.228 | -12.9 % | 163.665.726 |
| Champlain Investment Partners, LLC | 688.782 | -478.250 | -41.0 % | 28.997.722 |
| Soleus Capital Management, L.P. | 10.000 | -412.055 | -97.6 % | 421.000 |
| CITADEL ADVISORS LLC | 165.163 | -318.786 | -65.9 % | 6.953.363 |
| DIMENSIONAL FUND ADVISORS LP | 2.800.476 | -317.690 | -10.2 % | 117.901.225 |
| Amova Asset Management Americas, Inc. | 1.257.898 | -224.185 | -15.1 % | 52.957.506 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 05.06.2026 | FMR LLC | Passiv (13G/A) | 10,10 % | 8.059.903 | +0,40 pp | |
| 05.06.2026 | Abigail P. Johnson | Passiv (13G/A) | 10,10 % | 8.059.903 | +0,40 pp | |
| 13.05.2026 | Artisan Partners Holdings LP | Passiv (13G/A) | 6,90 % | 5.496.370 | -1,00 pp | |
| 13.05.2026 | Artisan Partners Limited Partnership | Passiv (13G/A) | 6,90 % | 5.496.370 | -1,00 pp | |
| 13.05.2026 | Artisan Investments GP LLC | Passiv (13G/A) | 6,90 % | 5.496.370 | -1,00 pp | |
| 13.05.2026 | Artisan Partners Asset Management Inc. | Passiv (13G/A) | 6,90 % | 5.496.370 | -1,00 pp | |
| 12.05.2026 | STATE STREET CORPORATION | Passiv (13G) | 6,30 % | 5.043.590 | +1,00 pp | |
| 06.05.2026 | Abigail P. Johnson | Passiv (13G/A) | 9,70 % | 7.703.849 | +2,50 pp | |
| 06.05.2026 | FMR LLC | Passiv (13G/A) | 9,70 % | 7.703.849 | +2,50 pp | |
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,20 % | 4.132.224 | Neu | |
| 29.04.2026 | Vanguard Portfolio Management | Passiv (13G) | 5,67 % | 4.512.852 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -10,08 pp | |
| 05.02.2026 | FMR LLC | Passiv (13G/A) | 7,20 % | 5.688.209 | -1,40 pp | |
| 05.02.2026 | Abigail P. Johnson | Passiv (13G/A) | 7,20 % | 5.688.209 | -1,40 pp | |
| 03.02.2026 | Artisan Partners Limited Partnership | Passiv (13G/A) | 7,90 % | 6.263.041 | -1,50 pp | |
| 03.02.2026 | Artisan Investments GP LLC | Passiv (13G/A) | 7,90 % | 6.263.041 | -1,50 pp | |
| 03.02.2026 | Artisan Partners Asset Management Inc. | Passiv (13G/A) | 7,90 % | 6.263.041 | -1,50 pp | |
| 03.02.2026 | Artisan Partners Holdings LP | Passiv (13G/A) | 7,90 % | 6.263.041 | -1,50 pp | |
| 08.01.2026 | Catherine D. Wood | Passiv (13G/A) | 4,92 % | 3.887.547 | -0,76 pp | |
| 08.01.2026 | ARK Investment Management LLC | Passiv (13G/A) | 4,92 % | 3.887.547 | -0,76 pp | |
| 12.11.2025 | Artisan Partners Limited Partnership | Passiv (13G/A) | 9,40 % | 7.370.467 | +1,30 pp | |
| 12.11.2025 | Artisan Investments GP LLC | Passiv (13G/A) | 9,40 % | 7.370.467 | +1,30 pp | |
| 12.11.2025 | Artisan Partners Holdings LP | Passiv (13G/A) | 9,40 % | 7.370.467 | +1,30 pp | |
| 12.11.2025 | Artisan Partners Asset Management Inc. | Passiv (13G/A) | 9,40 % | 7.370.467 | +1,30 pp | |
| 10.11.2025 | STATE STREET CORPORATION | Passiv (13G) | 5,30 % | 4.199.674 | Neu | |
| 05.11.2025 | Abigail P. Johnson | Passiv (13G/A) | 8,60 % | 6.735.697 | -1,60 pp | |
| 05.11.2025 | FMR LLC | Passiv (13G/A) | 8,60 % | 6.735.697 | -1,60 pp | |
| 04.11.2025 | Catherine D. Wood | Passiv (13G) | 5,68 % | 4.465.775 | +1,59 pp | |
| 04.11.2025 | ARK Investment Management LLC | Passiv (13G) | 5,68 % | 4.465.775 | +1,59 pp | |
| 12.08.2025 | Artisan Partners Holdings LP | Passiv (13G/A) | 8,10 % | 6.321.775 | +1,40 pp | |
| 12.08.2025 | Artisan Investments GP LLC | Passiv (13G/A) | 8,10 % | 6.321.775 | +1,40 pp | |
| 12.08.2025 | Artisan Partners Limited Partnership | Passiv (13G/A) | 8,10 % | 6.321.775 | +1,40 pp | |
| 12.08.2025 | Artisan Partners Asset Management Inc. | Passiv (13G/A) | 8,10 % | 6.321.775 | +1,40 pp | |
| 12.08.2025 | Wellington Group Holdings LLP | Passiv (13G/A) | 4,40 % | 3.473.772 | -1,11 pp | |
| 12.08.2025 | Wellington Investment Advisors Holdings LLP | Passiv (13G/A) | 4,40 % | 3.473.772 | -1,11 pp | |
| 12.08.2025 | Wellington Management Group LLP | Passiv (13G/A) | 4,40 % | 3.473.772 | -1,11 pp | |
| 01.08.2025 | BlackRock, Inc. | Passiv (13G/A) | 15,20 % | 11.930.018 | +6,80 pp | |
| 06.06.2025 | ARK Investment Management LLC | Passiv (13G/A) | 4,09 % | 3.205.231 | -0,96 pp | |
| 06.06.2025 | Catherine D. Wood | Passiv (13G/A) | 4,09 % | 3.205.231 | -0,96 pp | |
| 15.05.2025 | Artisan Investments GP LLC | Passiv (13G/A) | 6,70 % | 5.239.711 | -1,80 pp |
US Congress Trades (STOCK Act)
| Datum | Mitglied | Partei | Kammer | Typ | Betrag-Bereich |
|---|---|---|---|---|---|
| 03.03.2026 | Gilbert Cisneros | – | House | Kauf | $1,001 – $15,000 |
| 16.06.2025 | Gilbert Cisneros | – | House | Kauf | $1,001 – $15,000 |
Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →
Stammdaten
Veracyte, Inc. ist weltweit als Diagnostikunternehmen tätig. Das Unternehmen bietet Afirma Genomic Sequencing Classifier und Xpression Atlas zur Bestimmung, ob Patienten mit unbestimmten Befunden benigne Funde haben, um vermeidbare Operationen zu verhindern; Decipher Prostate Biopsy und Radical Prostatectomy für die Prostatakrebsdiagnose; Prosigna Breast Cancer Assay für die Brustkrebsdiagnose; Percepta Genomic Sequencing Classifier und Percepta Nasal Swab Test für die Lungenkrebsdiagnose; Envisia Genomic Classifier für die Diagnose der idiopathischen Lungenfibrose; und Immunoscore Colon Cancer Test für die Darmkrebsdiagnose. Das Unternehmen entwickelt auch Percepta Genomic Atlas zur Unterstützung von Lungenkrebsbehandlungsentscheidungen; Envisia Classifier, das nCounter-Analysesystem; und LymphMark für einen Lymphom-Subtyp-Test. Veracyte, Inc. hat Technologielizenzierungs- und Kooperationsverträge mit Johnson & Johnson, Acerta Pharma und CareDx. Das Unternehmen war früher als Calderome, Inc. bekannt und änderte seinen Namen im März 2008 in Veracyte, Inc. Veracyte, Inc. wurde 2006 gegründet und hat seinen Sitz in South San Francisco, Kalifornien.
Unternehmen & Branche
| Name | VERACYTE, INC. |
|---|---|
| Ticker | VCYT |
| CIK | 0001384101 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | 92337F107 |
|---|---|
| ISIN | US92337F1075 |
| Typ | Common Stock |
| Marktkapitalisierung | 3,80 Mrd. USD |
| KGV (P/E) | 58,45 |
| Beta | 1,90 |
Bewertung
| KBV (P/B) | 2,90 vs. 2,67 (2021) ▲ |
|---|---|
| KUV (P/S) | 7,36 vs. 13,35 (2021) ▼ |
| EV/EBITDA | 44,0 |
| FCF-Rendite | 3,3 % vs. -1,3 % (2021) ▲ |
Qualität & Bilanz
| Bruttomarge | 70,1 % |
|---|---|
| Operative Marge | 11,2 % vs. -37,3 % (2021) ▲ |
| Nettomarge | 12,8 % vs. -34,4 % (2021) ▲ |
| ROIC | 4,9 % vs. -6,8 % (2021) ▲ |
| Nettoverschuldung/EBITDA | -4,1 |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 2,67 | 1,59 | 1,93 | 2,62 | 2,55 | |
| KUV (P/S) | 13,35 | 5,76 | 5,58 | 6,91 | 6,46 | |
| EV/EBITDA | – | – | – | 73,0 | 38,1 | |
| FCF-Rendite | -1,3 % | -0,1 % | 1,7 % | 2,1 % | 3,8 % | |
| Qualität & Bilanz | ||||||
| Bruttomarge | – | 59,2 % | 63,6 % | 66,9 % | 70,1 % | |
| Operative Marge | -37,3 % | -13,9 % | -23,8 % | 3,6 % | 11,2 % | |
| Nettomarge | -34,4 % | -12,3 % | -20,6 % | 5,4 % | 12,8 % | |
| ROIC | -6,8 % | -3,4 % | -7,0 % | 2,0 % | 4,9 % | |
| Nettoverschuldung/EBITDA | – | – | – | -4,8 | -4,1 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 139.071.000 | 28.707.000 | 0,35 | 1.436.400.000 | 1.344.406.000 |
| 2025-12-31 | 10-K | 517.145.000 | 66.353.000 | 0,82 | 1.406.019.000 | 1.309.576.000 |
| 2025-09-30 | 10-Q | 131.872.000 | 19.137.000 | 0,24 | 1.367.787.000 | 1.257.667.000 |
| 2025-06-30 | 10-Q | 130.164.000 | -980.000 | -0,01 | 1.344.104.000 | 1.221.057.000 |
| 2025-03-31 | 10-Q | 114.473.000 | 7.047.000 | 0,09 | 1.315.411.000 | 1.194.936.000 |
| 2024-12-31 | 10-K | 445.764.000 | 24.138.000 | 0,31 | 1.300.035.000 | 1.175.966.000 |
| 2024-09-30 | 10-Q | 115.860.000 | 15.155.000 | 0,19 | 1.275.021.000 | 1.176.042.000 |
| 2024-06-30 | 10-Q | 114.428.000 | 5.734.000 | 0,07 | 1.234.327.000 | 1.132.523.000 |
| 2024-03-31 | 10-Q | 96.844.000 | -1.864.000 | -0,02 | 1.200.073.000 | 1.118.649.000 |
| 2023-12-31 | 10-K | 361.051.000 | -74.404.000 | -1,02 | 1.114.906.000 | 1.044.102.000 |
| 2023-09-30 | 10-Q | 90.108.000 | -29.618.000 | -0,41 | 1.124.943.000 | 1.054.059.000 |
| 2023-06-30 | 10-Q | 90.322.000 | -8.402.000 | -0,12 | 1.161.114.000 | 1.082.718.000 |
| 2023-03-31 | 10-Q | 82.422.000 | -8.091.000 | -0,11 | 1.157.119.000 | 1.081.259.000 |
| 2022-12-31 | 10-K | 296.536.000 | -36.560.000 | -0,51 | 1.156.422.000 | 1.075.200.000 |
| 2022-09-30 | 10-Q | 75.592.000 | -8.723.000 | -0,12 | 1.125.957.000 | 1.048.177.000 |
| 2022-06-30 | 10-Q | 72.864.000 | -9.532.000 | -0,13 | 1.144.198.000 | 1.064.151.000 |
| 2022-03-31 | 10-Q | 67.783.000 | -14.461.000 | -0,20 | 1.173.589.000 | 1.085.190.000 |
| 2021-12-31 | 10-K | 219.514.000 | -75.563.000 | -1,11 | 1.187.825.000 | 1.096.514.000 |
| 2021-09-30 | 10-Q | 60.370.000 | -14.129.000 | -0,20 | 1.186.356.000 | 1.107.080.000 |
| 2021-06-30 | 10-Q | 55.105.000 | -9.038.000 | -0,13 | 1.027.435.000 | 971.177.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Testing | 493,2 Mio. | 419,0 Mio. | 326,5 Mio. | 250,5 Mio. | 188,2 Mio. | 92,5 % | +17,7% | |
| Product | 14,3 Mio. | 13,7 Mio. | 15,6 Mio. | 12,6 Mio. | 11,5 Mio. | 2,7 % | +5,0% | |
| Biopharmaceutical And Other | 9,7 Mio. | 13,2 Mio. | 18,9 Mio. | 33,4 Mio. | 19,9 Mio. | 1,8 % | -26,5% | |
| Biopharmaceutical And Other Biopharmaceutical Revenue | 6,5 Mio. | 7,1 Mio. | 13,9 Mio. | 26,3 Mio. | – | 1,2 % | -8,6% | |
| Testing Other | 6,2 Mio. | 11,8 Mio. | 7,8 Mio. | 3,1 Mio. | – | 1,2 % | -47,5% | |
| Biopharmaceutical And Other Contract Manufacturing And Testing | 3,1 Mio. | 6,0 Mio. | 5,0 Mio. | 7,0 Mio. | – | 0,6 % | -47,9% | |
| Biopharmaceutical And Other Development Services | – | – | – | – | 10,4 Mio. | – | – | |
| Biopharmaceutical And Other Collaboration Milestones | – | – | – | – | 4,0 Mio. | – | – | |
| Biopharmaceutical And Other Contract Manufacturing | – | – | – | – | 2,9 Mio. | – | – | |
| Biopharmaceutical And Other Provision Of Data | – | – | – | – | 1,9 Mio. | – | – | |
| Biopharmaceutical And Other Contract Testing | – | – | – | – | 383.000 | – | – | |
| Biopharmaceutical And Other Milestones Excluding Collaboration | – | – | – | – | 350.000 | – | – |
Regionen
| Region | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| US | 496,6 Mio. | 423,5 Mio. | 334,5 Mio. | 262,9 Mio. | 201,0 Mio. | 96,0 % | +17,3% | |
| Non Us | 20,5 Mio. | 22,2 Mio. | 26,5 Mio. | 33,6 Mio. | 18,5 Mio. | 4,0 % | -7,6% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 06.05.2026 | 139,1 Mio. USD | 0,35 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | 131,9 Mio. USD | 0,24 |
| Q2 2025 | 30.06.2025 | 07.08.2025 | 130,2 Mio. USD | -0,01 |
| Q1 2025 | 31.03.2025 | 06.05.2026 | 114,5 Mio. USD | 0,09 |
| Q3 2024 | 30.09.2024 | 05.11.2025 | 115,9 Mio. USD | 0,19 |
| Q2 2024 | 30.06.2024 | 07.08.2025 | 114,4 Mio. USD | 0,07 |
| Q1 2024 | 31.03.2024 | 08.05.2025 | 96,8 Mio. USD | -0,02 |
| Q3 2023 | 30.09.2023 | 07.11.2024 | 90,1 Mio. USD | -0,41 |
| Q2 2023 | 30.06.2023 | 07.08.2024 | 90,3 Mio. USD | -0,12 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 06.05.2026 | 10-Q | 31.03.2026 | 36 Tage | SEC » |
| 26.02.2026 | 10-K | 31.12.2025 | 57 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 28.02.2025 | 10-K | 31.12.2024 | 59 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 07.08.2024 | 10-Q | 30.06.2024 | 38 Tage | SEC » |
| 08.05.2024 | 10-Q | 31.03.2024 | 38 Tage | SEC » |
| 29.02.2024 | 10-K | 31.12.2023 | 60 Tage | SEC » |
| 08.11.2023 | 10-Q | 30.09.2023 | 39 Tage | SEC » |
| 09.08.2023 | 10-Q | 30.06.2023 | 40 Tage | SEC » |
| 05.05.2023 | 10-Q | 31.03.2023 | 35 Tage | SEC » |
| 01.03.2023 | 10-K | 31.12.2022 | 60 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 03.08.2022 | 10-Q | 30.06.2022 | 34 Tage | SEC » |
| 04.05.2022 | 10-Q | 31.03.2022 | 34 Tage | SEC » |
| 28.02.2022 | 10-K | 31.12.2021 | 59 Tage | SEC » |
| 09.11.2021 | 10-Q | 30.09.2021 | 40 Tage | SEC » |
| 29.07.2021 | 10-Q | 30.06.2021 | 29 Tage | SEC » |
| 10.05.2021 | 10-Q | 31.03.2021 | 40 Tage | SEC » |
| 22.02.2021 | 10-K | 31.12.2020 | 53 Tage | SEC » |
| 02.11.2020 | 10-Q | 30.09.2020 | 33 Tage | SEC » |
| 30.07.2020 | 10-Q | 30.06.2020 | 30 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 16.03.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 04.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 13.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Principal Officers; Election of Directors… |
| 14.12.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 11.08.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 22.02.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 11.01.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 16.07.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 12.07.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 08.06.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 10.05.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 15.04.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.04.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 22.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 17.11.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 27.07.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 09.06.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.03.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-14 | 13 | 38,25 | 497 |
| 2026-05-08 | 116.620 | 40,76 | 4.753.431 |
| 2026-05-01 | 5.139 | 32,92 | 169.176 |
| 2026-04-30 | 18 | 31,78 | 572 |
| 2026-04-22 | 556 | 33,51 | 18.632 |
| 2026-04-21 | 3.005 | 33,45 | 100.517 |
| 2026-04-17 | 307 | 33,03 | 10.140 |
| 2026-04-10 | 1.440 | 31,35 | 45.144 |
| 2026-03-26 | 9.527 | 32,79 | 312.390 |
| 2026-03-23 | 2.159 | 31,84 | 68.743 |
| 2026-03-20 | 237 | 32,78 | 7.769 |
| 2026-03-19 | 10 | 33,28 | 333 |
| 2026-03-18 | 9.729 | 33,48 | 325.727 |
| 2026-03-13 | 23 | 30,93 | 711 |
| 2026-03-06 | 4.154 | 34,68 | 144.061 |
| 2026-03-03 | 8.368 | 36,01 | 301.332 |
| 2026-02-27 | 1.449 | 38,75 | 56.149 |
| 2026-02-06 | 527 | 34,86 | 18.371 |
| 2026-02-04 | 1.092 | 37,74 | 41.212 |
| 2026-01-23 | 2.830 | 43,80 | 123.954 |
| 2026-01-15 | 113 | 42,45 | 4.797 |
| 2026-01-12 | 291 | 42,04 | 12.234 |
| 2026-01-08 | 2.971 | 45,11 | 134.022 |
| 2025-12-19 | 14.572 | 42,04 | 612.607 |